Published in Blood Weekly, April 13th, 1998
H. Nakai and colleagues from Avigen Inc. and the University of Southern California, demonstrated that persistent expression of a transgene product transferred via rAAV vectors can be obtained in the presence of inhibitors following intramuscular injection in immunocompetent mice (abstract "Persistent Expression of Circulating Human Coagulation Factor IX in Mice Carrying Inhibitors Following Intramuscular Administration of an AAV Vector"). The research was presented at the Keystone Symposium, Molecular and Cellular Biology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.